Clinical Trial Update: Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT [Phase 1]

View source ↗

Summary

Phase I pilot study to characterize biodistribution, metabolism, and excretion of the novel PET radiotracer [18F]Fluorthanatrace (FTT) using PET/CT.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Drugs mentioned

• 18F-FluorThanatrace

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Suspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | Phase 1 | Status: RECRUITING